Friday, December 7, 2007


Cramer's pick CELG is getting beat daily... we added some a while back... ... ...
now seems like a good time to add some more.

-2.74 (-4.56%)

<< we do see some big green bars, and some red ones, but the biggest ones are green? hmmm?...and there is that last big green one, that one is neat.

BOTD's next buy target for CELG = 52 week low of $49.46 ... ... ... see you then?


BUY ON THE DIP said...


CELG is even for the year.

YTD gain 0% ...actually just a bit under....but you get the point.

BUY ON THE DIP said...

these guys said this a few days ago...

Wachovia initiates coverage on Celgene Corporation (Nasdaq: CELG) with an Outperform rating and $81-$93 valuation range.

Commenting on Celgene, the firm said, "Celgene has one of the highest growth rates in biotechnology driven by the global expansion of Revlimid which is poised to become a multi-billion dollar drug and one of the most successful biotechnology cancer compounds, in our opinion. Further, we are optimistic about the synergies that will arise from the acquistion of Pharmion."

Ragin' Cajun said...

You should do a series on buy the strength, citing AAPL a strong buy.

Love the site, keep it up!

Anonymous said...

Cramer backs CSCO too, look what happened, we got pwned

Anonymous said...

Maybe if you spent more time analyzing equities than putting up chicks and gay videos you would have seen that the DMA (28,-14 was still trending down on CELG when you bought on that dip.